Home Entheon Biomedical

Entheon Biomedical

In operation
IPO
Psychedelic Drug Developer

Basic Information

Entheon Biomedical Corp. has pioneered a leading addiction recovery solution, leveraging and optimizing the therapeutic potential of the DMT molecule. Committed to the legal development of regulated, safe, and effective therapies, and dedicated to educating the public and medical professionals about the efficacy of psychedelics when clinically managed in optimal settings.
Entheon Biomedical Corp.
Vancouver,BritishColumbia,Canada
15~50 people
January 01, 2019
--